The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Phenylketonuria (PKU)-Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2030
Synopsis
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global market for Phenylketonuria (PKU) was estimated to be worth US$ 1334 million in 2023 and is forecast to a readjusted size of US$ 2653.6 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phenylketonuria (PKU) by region & country, by Type, and by Application.
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type:
Medications
Supplements
Others
Segment by Application
Household
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phenylketonuria (PKU) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phenylketonuria (PKU) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
This report mainly focuses on the treatment for PKU.
The global market for Phenylketonuria (PKU) was estimated to be worth US$ 1334 million in 2023 and is forecast to a readjusted size of US$ 2653.6 million by 2030 with a CAGR of 10.2% during the forecast period 2024-2030
In the global Phenylketonuria (PKU) market, the main companies are Biomarin, Mead Johnson, Dr. Schär and Abbott, with a market share of more than 50%. The main regions are North America and Europe, with a market share of more than 70%. Supplements have the largest share of the Phenylketonuria (PKU) market, exceeding 50%. The application scenarios of Phenylketonuria (PKU) are mainly concentrated on Household, with a market share of approximately 70%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Phenylketonuria (PKU), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Phenylketonuria (PKU) by region & country, by Type, and by Application.
The Phenylketonuria (PKU) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phenylketonuria (PKU).
Market Segmentation
By Company
Biomarin
Mead Johnson
Abbott
Nutricia
Dr. Schär
Vitaflo
Cambrooke
PKU Perspectives
Firstplay Dietary
Segment by Type:
Medications
Supplements
Others
Segment by Application
Household
Hospital
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Phenylketonuria (PKU) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Phenylketonuria (PKU) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Phenylketonuria (PKU) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Index1 Market Overview
1.1 Phenylketonuria (PKU) Product Introduction
1.2 Global Phenylketonuria (PKU) Market Size Forecast
1.2.1 Global Phenylketonuria (PKU) Sales Value (2019-2030)
1.2.2 Global Phenylketonuria (PKU) Sales Volume (2019-2030)
1.2.3 Global Phenylketonuria (PKU) Sales Price (2019-2030)
1.3 Phenylketonuria (PKU) Market Trends & Drivers
1.3.1 Phenylketonuria (PKU) Industry Trends
1.3.2 Phenylketonuria (PKU) Market Drivers & Opportunity
1.3.3 Phenylketonuria (PKU) Market Challenges
1.3.4 Phenylketonuria (PKU) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Phenylketonuria (PKU) Players Revenue Ranking (2023)
2.2 Global Phenylketonuria (PKU) Revenue by Company (2019-2024)
2.3 Global Phenylketonuria (PKU) Players Sales Volume Ranking (2023)
2.4 Global Phenylketonuria (PKU) Sales Volume by Company Players (2019-2024)
2.5 Global Phenylketonuria (PKU) Average Price by Company (2019-2024)
2.6 Key Manufacturers Phenylketonuria (PKU) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Phenylketonuria (PKU) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Phenylketonuria (PKU)
2.9 Phenylketonuria (PKU) Market Competitive Analysis
2.9.1 Phenylketonuria (PKU) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Phenylketonuria (PKU) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylketonuria (PKU) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Medications
3.1.2 Supplements
3.1.3 Others
3.2 Global Phenylketonuria (PKU) Sales Value by Type
3.2.1 Global Phenylketonuria (PKU) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Phenylketonuria (PKU) Sales Value, by Type (2019-2030)
3.2.3 Global Phenylketonuria (PKU) Sales Value, by Type (%) (2019-2030)
3.3 Global Phenylketonuria (PKU) Sales Volume by Type
3.3.1 Global Phenylketonuria (PKU) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Phenylketonuria (PKU) Sales Volume, by Type (2019-2030)
3.3.3 Global Phenylketonuria (PKU) Sales Volume, by Type (%) (2019-2030)
3.4 Global Phenylketonuria (PKU) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Household
4.1.2 Hospital
4.2 Global Phenylketonuria (PKU) Sales Value by Application
4.2.1 Global Phenylketonuria (PKU) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Phenylketonuria (PKU) Sales Value, by Application (2019-2030)
4.2.3 Global Phenylketonuria (PKU) Sales Value, by Application (%) (2019-2030)
4.3 Global Phenylketonuria (PKU) Sales Volume by Application
4.3.1 Global Phenylketonuria (PKU) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Phenylketonuria (PKU) Sales Volume, by Application (2019-2030)
4.3.3 Global Phenylketonuria (PKU) Sales Volume, by Application (%) (2019-2030)
4.4 Global Phenylketonuria (PKU) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Phenylketonuria (PKU) Sales Value by Region
5.1.1 Global Phenylketonuria (PKU) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Phenylketonuria (PKU) Sales Value by Region (2019-2024)
5.1.3 Global Phenylketonuria (PKU) Sales Value by Region (2025-2030)
5.1.4 Global Phenylketonuria (PKU) Sales Value by Region (%), (2019-2030)
5.2 Global Phenylketonuria (PKU) Sales Volume by Region
5.2.1 Global Phenylketonuria (PKU) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Phenylketonuria (PKU) Sales Volume by Region (2019-2024)
5.2.3 Global Phenylketonuria (PKU) Sales Volume by Region (2025-2030)
5.2.4 Global Phenylketonuria (PKU) Sales Volume by Region (%), (2019-2030)
5.3 Global Phenylketonuria (PKU) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Phenylketonuria (PKU) Sales Value, 2019-2030
5.4.2 North America Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Phenylketonuria (PKU) Sales Value, 2019-2030
5.5.2 Europe Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Phenylketonuria (PKU) Sales Value, 2019-2030
5.6.2 Asia Pacific Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Phenylketonuria (PKU) Sales Value, 2019-2030
5.7.2 South America Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Phenylketonuria (PKU) Sales Value, 2019-2030
5.8.2 Middle East & Africa Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Phenylketonuria (PKU) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Phenylketonuria (PKU) Sales Value
6.2.1 Key Countries/Regions Phenylketonuria (PKU) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Phenylketonuria (PKU) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Phenylketonuria (PKU) Sales Value, 2019-2030
6.3.2 United States Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Phenylketonuria (PKU) Sales Value, 2019-2030
6.4.2 Europe Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Phenylketonuria (PKU) Sales Value, 2019-2030
6.5.2 China Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Phenylketonuria (PKU) Sales Value, 2019-2030
6.6.2 Japan Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Phenylketonuria (PKU) Sales Value, 2019-2030
6.7.2 South Korea Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Phenylketonuria (PKU) Sales Value, 2019-2030
6.8.2 Southeast Asia Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Phenylketonuria (PKU) Sales Value, 2019-2030
6.9.2 India Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Phenylketonuria (PKU) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biomarin
7.1.1 Biomarin Company Information
7.1.2 Biomarin Introduction and Business Overview
7.1.3 Biomarin Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Biomarin Phenylketonuria (PKU) Product Offerings
7.1.5 Biomarin Recent Development
7.2 Mead Johnson
7.2.1 Mead Johnson Company Information
7.2.2 Mead Johnson Introduction and Business Overview
7.2.3 Mead Johnson Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Mead Johnson Phenylketonuria (PKU) Product Offerings
7.2.5 Mead Johnson Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Phenylketonuria (PKU) Product Offerings
7.3.5 Abbott Recent Development
7.4 Nutricia
7.4.1 Nutricia Company Information
7.4.2 Nutricia Introduction and Business Overview
7.4.3 Nutricia Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Nutricia Phenylketonuria (PKU) Product Offerings
7.4.5 Nutricia Recent Development
7.5 Dr. Schär
7.5.1 Dr. Schär Company Information
7.5.2 Dr. Schär Introduction and Business Overview
7.5.3 Dr. Schär Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Dr. Schär Phenylketonuria (PKU) Product Offerings
7.5.5 Dr. Schär Recent Development
7.6 Vitaflo
7.6.1 Vitaflo Company Information
7.6.2 Vitaflo Introduction and Business Overview
7.6.3 Vitaflo Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Vitaflo Phenylketonuria (PKU) Product Offerings
7.6.5 Vitaflo Recent Development
7.7 Cambrooke
7.7.1 Cambrooke Company Information
7.7.2 Cambrooke Introduction and Business Overview
7.7.3 Cambrooke Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Cambrooke Phenylketonuria (PKU) Product Offerings
7.7.5 Cambrooke Recent Development
7.8 PKU Perspectives
7.8.1 PKU Perspectives Company Information
7.8.2 PKU Perspectives Introduction and Business Overview
7.8.3 PKU Perspectives Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 PKU Perspectives Phenylketonuria (PKU) Product Offerings
7.8.5 PKU Perspectives Recent Development
7.9 Firstplay Dietary
7.9.1 Firstplay Dietary Company Information
7.9.2 Firstplay Dietary Introduction and Business Overview
7.9.3 Firstplay Dietary Phenylketonuria (PKU) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Firstplay Dietary Phenylketonuria (PKU) Product Offerings
7.9.5 Firstplay Dietary Recent Development
8 Industry Chain Analysis
8.1 Phenylketonuria (PKU) Industrial Chain
8.2 Phenylketonuria (PKU) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Phenylketonuria (PKU) Sales Model
8.5.2 Sales Channel
8.5.3 Phenylketonuria (PKU) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of TablesList of Tables
Table 1. Phenylketonuria (PKU) Market Trends
Table 2. Phenylketonuria (PKU) Market Drivers & Opportunity
Table 3. Phenylketonuria (PKU) Market Challenges
Table 4. Phenylketonuria (PKU) Market Restraints
Table 5. Global Phenylketonuria (PKU) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Phenylketonuria (PKU) Revenue Market Share by Company (2019-2024)
Table 7. Global Phenylketonuria (PKU) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Phenylketonuria (PKU) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Phenylketonuria (PKU) Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Phenylketonuria (PKU) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Phenylketonuria (PKU) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Phenylketonuria (PKU)
Table 13. Global Phenylketonuria (PKU) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylketonuria (PKU) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Phenylketonuria (PKU) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Phenylketonuria (PKU) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Phenylketonuria (PKU) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Phenylketonuria (PKU) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Phenylketonuria (PKU) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Phenylketonuria (PKU) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Phenylketonuria (PKU) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Phenylketonuria (PKU) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Phenylketonuria (PKU) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Phenylketonuria (PKU) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Phenylketonuria (PKU) Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Phenylketonuria (PKU) Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Phenylketonuria (PKU) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Phenylketonuria (PKU) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Phenylketonuria (PKU) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Phenylketonuria (PKU) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Phenylketonuria (PKU) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Phenylketonuria (PKU) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Phenylketonuria (PKU) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Phenylketonuria (PKU) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Phenylketonuria (PKU) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Phenylketonuria (PKU) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Phenylketonuria (PKU) Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Phenylketonuria (PKU) Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Phenylketonuria (PKU) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Phenylketonuria (PKU) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Phenylketonuria (PKU) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Phenylketonuria (PKU) Sales Value by Region (2019-2024) & (%)
Table 44. Global Phenylketonuria (PKU) Sales Value by Region (2025-2030) & (%)
Table 45. Global Phenylketonuria (PKU) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Phenylketonuria (PKU) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Phenylketonuria (PKU) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Phenylketonuria (PKU) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Phenylketonuria (PKU) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Phenylketonuria (PKU) Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Phenylketonuria (PKU) Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Phenylketonuria (PKU) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Phenylketonuria (PKU) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Phenylketonuria (PKU) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Phenylketonuria (PKU) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Phenylketonuria (PKU) Sales Volume, (2025-2030) & (K Units)
Table 57. Biomarin Company Information
Table 58. Biomarin Introduction and Business Overview
Table 59. Biomarin Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Biomarin Phenylketonuria (PKU) Product Offerings
Table 61. Biomarin Recent Development
Table 62. Mead Johnson Company Information
Table 63. Mead Johnson Introduction and Business Overview
Table 64. Mead Johnson Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Mead Johnson Phenylketonuria (PKU) Product Offerings
Table 66. Mead Johnson Recent Development
Table 67. Abbott Company Information
Table 68. Abbott Introduction and Business Overview
Table 69. Abbott Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. Abbott Phenylketonuria (PKU) Product Offerings
Table 71. Abbott Recent Development
Table 72. Nutricia Company Information
Table 73. Nutricia Introduction and Business Overview
Table 74. Nutricia Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Nutricia Phenylketonuria (PKU) Product Offerings
Table 76. Nutricia Recent Development
Table 77. Dr. Schär Company Information
Table 78. Dr. Schär Introduction and Business Overview
Table 79. Dr. Schär Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Dr. Schär Phenylketonuria (PKU) Product Offerings
Table 81. Dr. Schär Recent Development
Table 82. Vitaflo Company Information
Table 83. Vitaflo Introduction and Business Overview
Table 84. Vitaflo Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Vitaflo Phenylketonuria (PKU) Product Offerings
Table 86. Vitaflo Recent Development
Table 87. Cambrooke Company Information
Table 88. Cambrooke Introduction and Business Overview
Table 89. Cambrooke Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Cambrooke Phenylketonuria (PKU) Product Offerings
Table 91. Cambrooke Recent Development
Table 92. PKU Perspectives Company Information
Table 93. PKU Perspectives Introduction and Business Overview
Table 94. PKU Perspectives Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. PKU Perspectives Phenylketonuria (PKU) Product Offerings
Table 96. PKU Perspectives Recent Development
Table 97. Firstplay Dietary Company Information
Table 98. Firstplay Dietary Introduction and Business Overview
Table 99. Firstplay Dietary Phenylketonuria (PKU) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Firstplay Dietary Phenylketonuria (PKU) Product Offerings
Table 101. Firstplay Dietary Recent Development
Table 102. Key Raw Materials Lists
Table 103. Raw Materials Key Suppliers Lists
Table 104. Phenylketonuria (PKU) Downstream Customers
Table 105. Phenylketonuria (PKU) Distributors List
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Phenylketonuria (PKU) Product Picture
Figure 2. Global Phenylketonuria (PKU) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Phenylketonuria (PKU) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Phenylketonuria (PKU) Sales Price (2019-2030) & (USD/Unit)
Figure 6. Phenylketonuria (PKU) Report Years Considered
Figure 7. Global Phenylketonuria (PKU) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Phenylketonuria (PKU) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Phenylketonuria (PKU) Revenue in 2023
Figure 10. Phenylketonuria (PKU) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Medications Picture
Figure 12. Supplements Picture
Figure 13. Others Picture
Figure 14. Global Phenylketonuria (PKU) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Phenylketonuria (PKU) Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Phenylketonuria (PKU) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Phenylketonuria (PKU) Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Phenylketonuria (PKU) Price by Type (2019-2030) & (USD/Unit)
Figure 19. Product Picture of Household
Figure 20. Product Picture of Hospital
Figure 21. Global Phenylketonuria (PKU) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Phenylketonuria (PKU) Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Phenylketonuria (PKU) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Phenylketonuria (PKU) Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Phenylketonuria (PKU) Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Phenylketonuria (PKU) Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Phenylketonuria (PKU) Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Phenylketonuria (PKU) Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Phenylketonuria (PKU) Sales Volume (%), (2019-2030)
Figure 38. United States Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 44. China Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 46. China Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 56. India Phenylketonuria (PKU) Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Phenylketonuria (PKU) Sales Value by Type (%), 2023 VS 2030
Figure 58. India Phenylketonuria (PKU) Sales Value by Application (%), 2023 VS 2030
Figure 59. Phenylketonuria (PKU) Industrial Chain
Figure 60. Phenylketonuria (PKU) Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
